- Home
- BRFH vs OTLK Comparison
BRFH vs OTLK Comparison
Compare BRFH & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRFH
- OTLK
- Stock Information
- Founded
- BRFH 2005
- OTLK 2010
- Country
- BRFH United States
- OTLK United States
- Employees
- BRFH N/A
- OTLK N/A
- Industry
- BRFH Packaged Foods
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRFH Consumer Staples
- OTLK Health Care
- Exchange
- BRFH Nasdaq
- OTLK Nasdaq
- Market Cap
- BRFH 47.3M
- OTLK 48.3M
- IPO Year
- BRFH N/A
- OTLK 2016
- Fundamental
- Price
- BRFH $3.02
- OTLK $1.76
- Analyst Decision
- BRFH Strong Buy
- OTLK Strong Buy
- Analyst Count
- BRFH 1
- OTLK 5
- Target Price
- BRFH $4.50
- OTLK $9.60
- AVG Volume (30 Days)
- BRFH 6.3K
- OTLK 792.9K
- Earning Date
- BRFH 08-13-2025
- OTLK 08-13-2025
- Dividend Yield
- BRFH N/A
- OTLK N/A
- EPS Growth
- BRFH N/A
- OTLK N/A
- EPS
- BRFH N/A
- OTLK 0.83
- Revenue
- BRFH $10,818,000.00
- OTLK N/A
- Revenue This Year
- BRFH $42.31
- OTLK N/A
- Revenue Next Year
- BRFH $40.92
- OTLK $379.84
- P/E Ratio
- BRFH N/A
- OTLK $2.15
- Revenue Growth
- BRFH 22.03
- OTLK N/A
- 52 Week Low
- BRFH $1.81
- OTLK $0.87
- 52 Week High
- BRFH $4.61
- OTLK $9.25
- Technical
- Relative Strength Index (RSI)
- BRFH 52.79
- OTLK 52.03
- Support Level
- BRFH $2.38
- OTLK $1.56
- Resistance Level
- BRFH $2.97
- OTLK $1.75
- Average True Range (ATR)
- BRFH 0.29
- OTLK 0.12
- MACD
- BRFH 0.05
- OTLK -0.01
- Stochastic Oscillator
- BRFH 46.04
- OTLK 38.14
About BRFH Barfresh Food Group Inc.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.